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“Proton-sensing receptors- 
therapeutic targets in the 
management of asthma?” 
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Rho GEF 
Na
+–H+ exchangers  
PKA  
G protein-coupled receptors 
pretty much explain all biological phenomena  
and are the only thing worth studying 
GPCR agonists are physiological, 
pathological, and therapeutic regulators 
of ASM contractile state 
1. Contractile state is a function of the dynamic balance of 
(pro-contractile) Gq-coupled vs (pro-relaxant) Gs-coupled 
GPCR activation. 
2. Physiological: Parasympathetic innervation providing 
acetycholine (ACh) activating Gq-coupled m3 muscarinic 
acetylcholine receptor (m3mAChR) is principal regulator of 
physiological tone. 
GPCR agonists are physiological, 
pathological, and therapeutic regulators 
of ASM contractile state 
3. Pathological: Inflammation can cause increased 
parasympathetic ACh release (m3mAChR), and numerous 
inflammatory mediators (e.g. histamine, LTC4/LTD4, 
endothelin, serotonin) can activate Gq-coupled receptors 
on ASM. 
4. Therapeutic: Many anti- asthma/COPD drug either: 1) 
block Gq-coupled receptors (monteleukast for CysLT1R, 
tiotropium for m3mAChR); or 2) activate bronchodilatory 
Gs-coupled receptors (beta-agonists).  
Proton-sensing GPCRs 
• Subfamily of GPCRs linked by sequence 
similarity: 
–  OGR1, G2A ? (Gq) 
–  GPR4, TDAG8 (Gs) 
• Can  exhibit high level of constitutive activity 
• Originally thought to be receptors activated 
by lysolipids  
• Subsequently found to signal in response to 
lowering extracellular pH 
Sequence alignment identifies OGR1, GPR4, TDAG8, and G2A as family of GPCRs 
Radu C G et al. PNAS 2005;102:1632-1637 
Expressed OGR1 exhibits constitutive and pH-dependent IP production 
pH-dependent accumulation of intracellular cAMP by GPR4, TDAG8  
How do protons activate these GPCRs? 
Predicted structure, proton-sensing histidine residues in 
OGR1, GPR4, and TDAG8 
Mutation of putative proton-sensing histidines inhibits 
pH sensing by OGR1 
Ludwig et al. Nature 2003 
Gq-coupled receptor signaling in ASM 
Gs-coupled receptor signaling 
Gs-coupled receptors antagonize 
Gq-coupled receptor-mediated 
contraction 
• Primarily via PKA activation 
• Inhibits increase in intracellular Ca2+ 
• Inhibits cellular sensitization to Ca2+ 
PKA targets: 
 
A. Controlling Ca 2+ release entry: 
 
1.    Gq-GPCR 
2.    Gq 
3.     PLC 
4. Phospholamban/IP3R 
5. K+ and Ca2+ channels 
 
B. Calcium Sensitization: 
 
• Calcium/calmodulin/MLCK 
• Rho Kinase reg of MLCP 
 
Objectives 
• Characterize the proton sensitive GPCRs 
in the ASM 
• Determine the intracellular signaling 
mechanisms activated by proton sensitive 
receptors in the ASM 
• Determine the functional consequences of 
changing pH in the microenvironment of 
the ASM 
 
Current proposed mechanisms 

Fig 1 
Source: Journal of Allergy and Clinical Immunology 2004; 113:610-619 (DOI:10.1016/j.jaci.2003.12.034 ) 
Copyright © 2004 American Academy of Allergy, Asthma and Immunology Terms and Conditions 
Respiratory fluid Condition Measured pH 
EBC (deaerated to remove CO2) Health 7.7±0.49 
Asthma exacerbation 5.2±0.21 
Stable mild asthma 7.6 (7.55-7.65) 
Stable moderate asthma 
7.27 (CI, 7.15-
7.39) 
Stable COPD 
7.16 (CI, 7.09-
7.23) 
COPD exacerbation 6.25 
Stable bronchiectasis 
7.11 (CI, 7.04-
7.19) 
Intubated: healthy 7.8±0.28 
Intubated: sepsis 5.92 
Intubated: ARDS 6 
Tracheal fluid in vivo (transcricoid pH probe) Health w/GER episodes 7.0 (6.5-7.4) 
To <4.0 
Bronchial fluid in vivo (pH probe inserted 
through bronchoscope) Health 7.1Â±0.1 
Airway submucosal gland secretion (explanted 
tissue) Health 6.97 
Nasal fluid in vivo (pH probe) Health 7.4-7.9 
Health 6.9-7.4 
Health 7.31 (7.2-7.5) 
Allergic rhinitis 7.8-8.5 
Chronic hypertrophic 
rhinitis 7.14 (6.6-7.6) 
From Ricciardolo, Gaston, and Hunt JACI 2004  
Airway pH tends to alkaline, but decreases with allergic inflammation 
Corticosteroids reverse the reduced airway pH 
 associated with acute asthma exacerbations 
Hunt et al. Am J Respir Crit Care Med. 2000 
Proton-sensing GPCRs may represent another mechanisms 
mediating effects of more subtle decreases in airway pH 


PKA activation by ↓pHo not necessarily dependent on COX: 
Pleiotropic signaling? 
Akt, p42/p44 activation by ↓pHo is not via RTK transactivation 
AG1478 AG1296 Vehicle Vehicle 
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Expression of proton sensitive receptors in ASM 


Signaling looks good. 
What about function? 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASM cell contraction: Magnetic Twisting Cytometry (MTC) 





Summary of results 
• Stimulation of ASM cells with increasing 
concentration of protons leads to activation of 
p42/p44 MAPK and calcium elevation suggesting 
Gq-mediated responses 
• Acid stimulation of ASM cells also results in the 
activation of PKA that is not necessarily COX 
dependent 
• Protease activity cannot account for activation of 
RTK pathways 
• Acid contracts ASM tissue and ASM cells 
 
Summary of results 
• OGR1 is the predominant proton sensitive 
receptor in the ASM cells 
• OGR1 knockdown in human ASM inhibits 
acid-induced PKA and Ca2+ mobilization 
• OGR1 knockdown in human ASM inhibits 
acid-induced contraction 
• OGR1 knockout in murine ASM inhibits 
acid-induced contraction 
 
 
Mixed bag of effects (context-
dependent)- What to do? 
• Control pHo or pHi  
• Block, activate, or bias GPCR signaling: 
  a. Downstream signaling- usual suspect 
pathway inhibitors, COX inhibitors, antagonists 
of induced GPCR ligands, tyrphostins. 
  b. At the receptor level for proton-sensing 
GPCRs; this quite hard given no ligands! 
 
We have characterized a class of OGR1 ligands 
 (allosteric modulators actually) 
 and  data to date that suggest we can bias 
 OGR1 signaling 
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A subclass of (can’t tell you which because confidential!) 
 regulate OGR1-mediated Ca2+ mobilization. 
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Some ligands appear balanced (L), some biased (S) 
S stimulates Gs/ PKA but not Gq/Ca2+ 
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Up next:  
 
Characterizing newly discovered small molecule 
 OGR1 ligands and their capacity 
 for biasing Gs vs Gq signaling 
(Gs bias means broncholdilation!) 
 
a.Human ASM cells and tissue 
b.Guinea pig model of airway regulation by acid 
c. OGR1 -/- mouse  
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